← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

ALC logoAlcon Inc.(ALC)Earnings, Financials & Key Ratios

ALC•NYSE
$63.88
$31.13B mkt cap·32.3× P/E·Price updated May 7, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDental and vision care devices
AboutAlcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.Show more
  • Revenue$10.4B+4.9%
  • EBITDA$2.55B-3.4%
  • Net Income$980M-3.7%
  • EPS (Diluted)1.98-3.4%
  • Gross Margin55.24%-0.7%
  • EBITDA Margin24.53%-8.0%
  • Operating Margin13.08%-8.3%
  • Net Margin9.42%-8.3%
  • ROE4.5%-6.8%
  • ROIC4.02%-5.8%
  • Debt/Equity0.24
Analysis→Technical→

ALC Key Insights

Alcon Inc. (ALC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓FCF machine: 16.6% free cash flow margin
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Trading at only 1.4x book value

✗Weaknesses

  • ✗Weak 3Y average ROE of 4.7%
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ALC Price & Volume

Alcon Inc. (ALC) stock price & volume — 10-year historical chart

Loading chart...

ALC Growth Metrics

Alcon Inc. (ALC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years4.78%
5 Years8.77%
3 Years6.06%
TTM6.61%

Profit CAGR

10 Years12.71%
5 Years-
3 Years43.02%
TTM-27.2%

EPS CAGR

10 Years12.5%
5 Years-
3 Years42.8%
TTM-26.67%

Return on Capital

10 Years1.48%
5 Years3.73%
3 Years4.6%
Last Year4.81%

ALC Recent Earnings

Alcon Inc. (ALC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 5, 2026
EPS
$0.85
Est $0.80
+6.3%
Revenue
$2.6B
Est $2.6B
-0.9%
Q1 2026
Feb 24, 2026
EPS
$0.78
Est $0.79
-1.3%
Revenue
$2.6B
Est $2.7B
-1.9%
Q4 2025
Nov 11, 2025
EPS
$0.79
Est $0.77
+2.6%
Revenue
$2.6B
Est $2.7B
-3.6%
Q3 2025
Aug 19, 2025
EPS
$0.76
Est $0.71
+7.0%
Revenue
$2.6B
Est $2.7B
-2.1%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.85vs $0.80+6.3%
$2.6Bvs $2.6B-0.9%
Q1 2026Feb 24, 2026
$0.78vs $0.79-1.3%
$2.6Bvs $2.7B-1.9%
Q4 2025Nov 11, 2025
$0.79vs $0.77+2.6%
$2.6Bvs $2.7B-3.6%
Q3 2025Aug 19, 2025
$0.76vs $0.71+7.0%
$2.6Bvs $2.7B-2.1%
Based on last 12 quarters of dataView full earnings history →

ALC Peer Comparison

Alcon Inc. (ALC) competitors in Dental and vision care devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
BAX logoBAXBaxter International Inc.Direct Competitor9.04B17.51-10.015.72%-9.7%-16.5%1.64
HSIC logoHSICHenry Schein, Inc.Direct Competitor8.09B70.5021.564.03%3.02%8.24%0.77
HOLX logoHOLXHologic, Inc.Direct Competitor16.97B76.0130.531.74%13.18%11.01%0.52
IDXX logoIDXXIDEXX Laboratories, Inc.Direct Competitor45.45B572.2043.7510.42%24.63%70.87%0.67
EW logoEWEdwards Lifesciences CorporationDirect Competitor47.72B82.7745.2311.55%17.64%10.35%0.07
STE logoSTESTERIS plcDirect Competitor21B213.6834.466.24%12.14%9.87%0.33
JNJ logoJNJJohnson & JohnsonProduct Competitor536.23B222.5138.434.3%27.26%31.69%0.51
ABT logoABTAbbott LaboratoriesProduct Competitor151.3B87.0111.394.59%31.88%27.26%0.32

Compare ALC vs Peers

Alcon Inc. (ALC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BAX

Most directly comparable listed peer for ALC.

Scale Benchmark

vs LLY

Larger-name benchmark to compare ALC against a more recognizable public peer.

Peer Set

Compare Top 5

vs BAX, HSIC, HOLX, IDXX

ALC Income Statement

Alcon Inc. (ALC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue6.79B7.15B7.51B6.83B8.29B8.72B9.46B9.91B10.4B10.58B
Revenue Growth %2.97%5.32%4.96%-8.99%21.34%5.14%8.47%4.82%4.94%6.61%
Cost of Goods Sold3.59B3.96B3.85B3.89B3.64B3.97B4.21B4.4B4.66B4.77B
COGS % of Revenue52.83%55.38%51.23%56.97%43.89%45.53%44.51%44.39%44.76%-
Gross Profit
3.2B▲ 0%
3.19B▼ 0.4%
3.66B▲ 14.7%
2.94B▼ 19.7%
4.65B▲ 58.2%
4.75B▲ 2.1%
5.25B▲ 10.5%
5.51B▲ 5.1%
5.75B▲ 4.2%
5.81B▲ 0%
Gross Margin %47.17%44.62%48.77%43.03%56.11%54.47%55.49%55.62%55.24%54.95%
Gross Profit Growth %2.99%-0.37%14.72%-19.72%58.23%2.06%10.51%5.05%4.23%-
Operating Expenses3.28B3.44B3.85B3.42B4.07B4.08B4.21B4.1B4.38B4.51B
OpEx % of Revenue48.31%48.09%51.27%50.08%49.11%46.76%44.51%41.36%42.16%-
Selling, General & Admin2.6B2.8B2.85B2.69B3.08B3.07B3.21B3.25B3.45B3.48B
SG&A % of Revenue38.22%39.16%37.92%39.43%37.1%35.2%33.94%32.79%33.16%-
Research & Development584M587M656M673M842M702M859M876M990M1.01B
R&D % of Revenue8.6%8.21%8.74%9.85%10.16%8.05%9.09%8.84%9.52%-
Other Operating Expenses101M52M346M55M154M306M140M-27M-54M1000K
Operating Income
-77M▲ 0%
-248M▼ 222.1%
-187M▲ 24.6%
-482M▼ 157.8%
580M▲ 220.3%
672M▲ 15.9%
1.04B▲ 54.6%
1.41B▲ 36.0%
1.36B▼ 3.8%
1.3B▲ 0%
Operating Margin %-1.13%-3.47%-2.49%-7.05%7%7.71%10.99%14.26%13.08%12.31%
Operating Income Growth %-870%-222.08%24.6%-157.75%220.33%15.86%54.61%36%-3.75%-
EBITDA1.24B1.38B1.28B1.24B1.8B1.83B2.26B2.64B2.55B2.17B
EBITDA Margin %18.27%19.27%16.99%18.17%21.73%21.01%23.9%26.65%24.53%20.53%
EBITDA Growth %-1.46%11.04%-7.45%-2.67%45.13%1.68%23.37%16.86%-3.41%2.98%
D&A (Non-Cash Add-back)1.32B1.63B1.46B1.72B1.22B1.16B1.22B1.23B1.19B866.05M
EBIT-101M-274M-206.28M-542.6M539.14M616.59M1.02B1.45B1.16B1.26B
Net Interest Income-27M-21.84M-126.23M-125.3M-117.25M-121.87M-155M-104.73M-204M-221.99M
Interest Income01.99M8.21M6.37M3.01M16.52M34M81.45M00
Interest Expense27M23.83M134.44M131.67M120.26M138.4M189M186.18M0152.99M
Other Income/Expense-50M-52M-145M-153M-162M-209M-207M-157M-200M-321.52M
Pretax Income
-127M▲ 0%
-300M▼ 136.2%
-332M▼ 10.7%
-635M▼ 91.3%
418M▲ 165.8%
463M▲ 10.8%
832M▲ 79.7%
1.26B▲ 51.0%
1.16B▼ 7.6%
981.34M▲ 0%
Pretax Margin %-1.87%-4.19%-4.42%-9.29%5.04%5.31%8.8%12.67%11.15%9.27%
Income Tax-383M-73M324M-104M42M128M-142M238M180M166.01M
Effective Tax Rate %301.57%24.33%-97.59%16.38%10.05%27.65%-17.07%18.95%15.52%16.92%
Net Income
256M▲ 0%
-227M▼ 188.7%
-656M▼ 189.0%
-531M▲ 19.1%
376M▲ 170.8%
335M▼ 10.9%
974M▲ 190.7%
1.02B▲ 4.5%
980M▼ 3.7%
815.33M▲ 0%
Net Margin %3.77%-3.17%-8.74%-7.77%4.54%3.84%10.3%10.27%9.42%7.71%
Net Income Growth %250.59%-188.67%-188.99%19.05%170.81%-10.9%190.75%4.52%-3.73%-27.2%
Net Income (Continuing)256M-227M-656M-531M376M335M974M1.02B980M815.33M
Discontinued Operations0000000000
Minority Interest000000001M1.01M
EPS (Diluted)
0.52▲ 0%
-0.46▼ 188.5%
-1.34▼ 191.3%
-1.09▲ 18.7%
0.76▲ 169.7%
0.68▼ 10.5%
1.96▲ 188.2%
2.05▲ 4.6%
1.98▼ 3.4%
1.66▲ 0%
EPS Growth %248.57%-188.46%-191.3%18.66%169.72%-10.53%188.24%4.59%-3.41%-26.67%
EPS (Basic)0.52-0.46-1.34-1.090.770.681.982.061.99-
Diluted Shares Outstanding488.7M488.7M488.2M489M493.4M494.4M496.5M497.5M496.2M490.2M
Basic Shares Outstanding488.7M488.7M488.2M489M490M491.4M493M494.4M494.95M487.2M
Dividend Payout Ratio----14.39%30.83%11.91%12.77%16.94%-

ALC Balance Sheet

Alcon Inc. (ALC) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets3.29B3.4B4.24B4.99B5.39B5.19B5.65B6.31B6.45B6.66B
Cash & Short-Term Investments172M258M855M1.57B1.58B980M1.1B1.83B1.61B1.67B
Cash Only172M227M822M1.56B1.57B980M1.09B1.68B1.53B1.59B
Short-Term Investments031M33M12M3M07M154M80M81.44M
Accounts Receivable1.52B1.41B1.51B1.47B1.59B1.99B1.89B2.08B1.94B2.02B
Days Sales Outstanding81.5871.7473.5178.4270.1383.2872.8176.6868.1568.25
Inventory1.3B1.44B1.5B1.64B1.9B2.11B2.32B2.27B2.39B2.45B
Days Inventory Outstanding132.55132.69142.83154.14190.47193.95201.41188.18187.44185.04
Other Current Assets237M249M275M213M224M8M226M12M509M515.8M
Total Non-Current Assets24.1B23.66B23.42B22.61B22.61B24.02B23.97B24.04B25.11B25.14B
Property, Plant & Equipment2.56B2.88B3.44B3.78B4.08B4.42B4.72B4.84B5.22B5.25B
Fixed Asset Turnover2.65x2.48x2.18x1.81x2.03x1.97x2.00x2.05x1.99x2.05x
Goodwill8.89B8.9B8.9B8.9B8.9B8.97B8.93B8.95B9.26B9.31B
Intangible Assets11.54B10.68B10.23B9.1B8.77B9.69B9.06B8.59B9.01B8.93B
Long-Term Investments51M86M59M40M52M108M319M751M768M3.07B
Other Non-Current Assets528M450M433M389M399M422M496M495M855M2.03B
Total Assets
27.39B▲ 0%
27.06B▼ 1.2%
27.66B▲ 2.2%
27.6B▼ 0.2%
28B▲ 1.4%
29.21B▲ 4.3%
29.61B▲ 1.4%
30.35B▲ 2.5%
31.55B▲ 4.0%
31.79B▲ 0%
Asset Turnover0.25x0.26x0.27x0.25x0.30x0.30x0.32x0.33x0.33x0.34x
Asset Growth %-1.27%-1.19%2.19%-0.2%1.45%4.32%1.39%2.48%3.98%15.84%
Total Current Liabilities1.78B1.89B2.3B2.26B2.47B2.74B2.4B2.28B3.05B3.02B
Accounts Payable672M663M833M876M903M861M811M773M926M924.01M
Days Payables Outstanding68.3661.0979.0582.1390.5779.1870.3564.1472.5969.66
Short-Term Debt65M47M261M169M107M97M48M101M575M660.58M
Deferred Revenue (Current)138M94M97M110M108M89M77.97M72.84M00
Other Current Liabilities417M490M559M532M586M907M627.03M539.16M1.47B1.23B
Current Ratio1.85x1.80x1.84x2.21x2.18x1.90x2.35x2.77x2.12x2.12x
Quick Ratio1.12x1.03x1.19x1.48x1.41x1.13x1.39x1.77x1.33x1.33x
Cash Conversion Cycle145.77143.34137.28150.42170.03198.05203.87200.72183183.63
Total Non-Current Liabilities2.58B2.53B6.05B6.52B6.27B6.75B6.59B6.52B6.47B6.52B
Long-Term Debt01.83B3.22B3.95B3.97B4.54B4.68B4.54B4.16B4.18B
Capital Lease Obligations84M89M280M315M339M359M335M429M429M1.75B
Deferred Tax Liabilities1.64B1.53B1.39B1.2B1.03B1.06B797M724M02.72B
Other Non-Current Liabilities857M-918M1.17B1.06B940M786M752M739M1.88B4.63B
Total Liabilities4.36B4.42B8.35B8.78B8.74B9.53B8.99B8.79B9.52B9.54B
Total Debt149M136M3.8B4.5B4.48B5.07B5.13B5.14B5.25B5.29B
Net Debt-23M-91M2.98B2.94B2.9B4.09B4.04B3.45B3.72B3.7B
Debt / Equity0.01x0.01x0.20x0.24x0.23x0.26x0.25x0.24x0.24x0.24x
Debt / EBITDA0.12x0.10x2.98x3.62x2.49x2.77x2.27x1.94x2.06x2.44x
Net Debt / EBITDA-0.02x-0.07x2.34x2.37x1.61x2.23x1.79x1.31x1.46x1.46x
Interest Coverage-3.74x-11.50x-1.53x-4.12x4.48x4.46x5.40x7.78x-8.23x
Total Equity
23.03B▲ 0%
22.64B▼ 1.7%
19.3B▼ 14.7%
18.82B▼ 2.5%
19.26B▲ 2.3%
19.68B▲ 2.2%
20.62B▲ 4.8%
21.55B▲ 4.5%
22.04B▲ 2.2%
22.25B▲ 0%
Equity Growth %0.07%-1.69%-14.74%-2.49%2.31%2.19%4.81%4.5%2.24%12.14%
Book Value per Share47.1246.3239.5438.4939.0339.8041.5443.3244.4145.40
Total Shareholders' Equity23.03B22.64B19.3B18.82B19.26B19.68B20.62B21.55B22.03B22.25B
Common Stock022.64B20M20M20M20M20M20M20M20.11M
Retained Earnings22.94B22.65B-547M0000000
Treasury Stock0000000000
Accumulated OCI87M-11M19.28B18.8B19.24B19.66B20.6B21.53B22.01B22.23B
Minority Interest000000001M1.01M

ALC Cash Flow Statement

Alcon Inc. (ALC) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations1.22B1.14B920M823M1.34B1.22B1.39B2.08B2.27B2.27B
Operating CF Margin %17.93%15.94%12.25%12.04%16.22%13.96%14.68%20.96%21.83%-
Operating CF Growth %-2.17%-6.4%-19.3%-10.54%63.43%-9.52%14.05%49.64%9.34%40.58%
Net Income256M-227M-656M-531M376M335M974M1.02B980M815.33M
Depreciation & Amortization1.3B1.62B1.43B1.62B1.22B1.12B1.22B1.23B1.19B1.02B
Stock-Based Compensation71M93M83M105M138M140M144M150M0-80M
Deferred Taxes-383M-73M324M-104M42M128M-142M238M00
Other Non-Cash Items53M-355M-208M-225M-116M13M-377.78M-368M400M770.94M
Working Capital Changes-84M80M-48M-45M-314M-522M-431.22M-189M-300M-253.79M
Change in Receivables-54M53M-115M43M-198M-164M-117.41M-55M05.78M
Change in Inventory-87M-150M-108M-159M-326M-217M-289.26M-47M0-2.4M
Change in Payables044M84M-21M60M-48M-54.44M-15M03.93M
Cash from Investing-679M-1B-1.01B-572M-1.2B-1.86B-1.09B-1.17B-1.34B-971.35M
Capital Expenditures-496M-712M-676M-567M-1.18B-745M-660M-473M-543M-639.38M
CapEx % of Revenue7.3%9.95%9%8.3%14.23%8.55%6.98%4.77%5.22%-
Acquisitions-70M-239M-283M6.37M480M-666M-10M-220M-692M-114.96M
Investments----------
Other Investing1M0-1M-82M-480M-485M-177.3M-205M-109M-181.69M
Cash from Financing-539M-78M659M466M-123M-8M-211M-322M-1.12B-1.13B
Debt Issued (Net)-112.11M-5.96M3.36B536M-63M208M-7M-137M-96M-50.68M
Equity Issued (Net)000-16M-22M-50M-49M0-723M-758.01M
Dividends Paid0000-54.11M-103.28M-116M-130M-166M-160.65M
Share Repurchases000-16M-22M-50M-49M0-723M-758.01M
Other Financing-426.89M-72.04M-2.7B-54M16.11M-62.72M-39M-55M-134M-156.4M
Net Change in Cash
10M▲ 0%
55M▲ 450.0%
595M▲ 981.8%
735M▲ 23.5%
18M▼ 97.6%
-595M▼ 3405.6%
114M▲ 119.2%
582M▲ 410.5%
-149M▼ 125.6%
169.4M▲ 0%
Free Cash Flow
722M▲ 0%
428M▼ 40.7%
244M▼ 43.0%
256M▲ 4.9%
165M▼ 35.5%
472M▲ 186.1%
537M▲ 13.8%
1.41B▲ 162.0%
1.73B▲ 22.8%
1.7B▲ 0%
FCF Margin %10.63%5.98%3.25%3.75%1.99%5.41%5.68%14.2%16.61%16.11%
FCF Growth %-2.3%-40.72%-42.99%4.92%-35.55%186.06%13.77%162.01%22.81%5.57%
FCF per Share1.480.880.500.520.330.951.082.833.483.48
FCF Conversion (FCF/Net Income)4.76x-5.02x-1.40x-1.55x3.58x3.63x1.43x2.04x2.32x2.09x
Interest Paid00000000063M
Taxes Paid0000000000

ALC Key Ratios

Alcon Inc. (ALC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)1.11%-0.99%-3.13%-2.79%1.97%1.72%4.83%4.83%4.5%3.69%
Return on Invested Capital (ROIC)-0.25%-0.82%-0.63%-1.64%1.98%2.19%3.22%4.27%4.02%4.02%
Gross Margin47.17%44.62%48.77%43.03%56.11%54.47%55.49%55.62%55.24%54.95%
Net Margin3.77%-3.17%-8.74%-7.77%4.54%3.84%10.3%10.27%9.42%7.71%
Debt / Equity0.01x0.01x0.20x0.24x0.23x0.26x0.25x0.24x0.24x0.24x
Interest Coverage-3.74x-11.50x-1.53x-4.12x4.48x4.46x5.40x7.78x-8.23x
FCF Conversion4.76x-5.02x-1.40x-1.55x3.58x3.63x1.43x2.04x2.32x2.09x
Revenue Growth2.97%5.32%4.96%-8.99%21.34%5.14%8.47%4.82%4.94%6.61%

ALC Frequently Asked Questions

Alcon Inc. (ALC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Alcon Inc. (ALC) reported $10.58B in revenue for fiscal year 2025. This represents a 62% increase from $6.52B in 2015.

Alcon Inc. (ALC) grew revenue by 4.9% over the past year. Growth has been modest.

Yes, Alcon Inc. (ALC) is profitable, generating $815.3M in net income for fiscal year 2025 (9.4% net margin).

Dividend & Returns

Yes, Alcon Inc. (ALC) pays a dividend with a yield of 0.52%. This makes it attractive for income-focused investors.

Alcon Inc. (ALC) has a return on equity (ROE) of 4.5%. This is below average, suggesting room for improvement.

Alcon Inc. (ALC) generated $1.70B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ALC

Alcon Inc. (ALC) financial analysis — history, returns, DCA and operating performance tools

Full ALC Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.